Home > Boards > Canadian > Cannabis >

Auxly Cannabis Group Inc. (CBWTF)

Add CBWTF Price Alert      Hide Sticky   Hide Intro
Moderator: Diogenes of Sinope, TheGreatGreenRush
Search This Board: 
Last Post: 6/18/2019 1:07:23 PM - Followers: 165 - Board type: Free - Posts Today: 0


Current Share Structure

Current O/S: 606,189,817 2/26/2019
Current Float: 461,717,092 2/26/2019

Auxly Signs Definitive Agreement With Curative Cannabis

VANCOUVER, British Columbia, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (the "Company") is pleased to announce that the Company has signed a definitive agreement (the “Transaction”) with 2368523 Ontario Limited (d/b/a) Curative Cannabis ("Curative"). The Company will acquire 46% of the common shares of Curative and enter into a long-term cannabis purchase and sale agreement to fund the construction and development costs of Curative’s cannabis cultivation facility in Chatham-Kent, Ontario (the “Facility”).

The Facility is designed as a purpose-built indoor facility for the production of ultra-premium cannabis product. With an initial footprint spanning approximately 30,000 square feet, the first phase of the Facility is expected to yield approximately 2,900 kg of cannabis per annum. Curative anticipates bringing a unique ultra-premium cannabis product to Canadian recreational cannabis consumers through its proprietary genetics database of over 90 stable, and highly sought-after, cannabis strains (the "Genetic Library"). The first phase of the Facility, being built to EU GMP standards, is currently under construction with an anticipated completion and Health Canada evidence package submission date of March 2019. Curative’s Facility rests on a 33-acre land parcel thereby providing ample room for Facility expansion. Curative has already received municipal approval for the expansion of the Facility for up to an additional 120,000 square feet of indoor cultivation space.

Pursuant to the Transaction, the Company has entered into a share purchase agreement with certain shareholders of Curative, whereby the Company has agreed to purchase 46% of the common shares of Curative from certain Curative shareholders, in exchange for the issuance of 5,056,026 common shares of the Company (the “Consideration Shares”). The Company will also enter into a long-term cannabis purchase and sale agreement with Curative, pursuant to which the Company will fund the construction and development costs of the Facility in exchange for the right to purchase 50% of the cannabis products and cannabis trim produced at the Facility at an offtake price equal to Curative’s direct cost of cultivation plus 10%.

Additionally, the Company shall be granted: (i) a right of first refusal over any future expansion of the Facility and/or the proposed construction of any new cannabis production facility by Curative and if the Company exercises such right of refusal it shall be entitled to receive a comparable offtake purchase arrangement as it received under the Transaction; and (ii) unfettered access and control to Curative’s Genetic Library which can be transferred (at the Company's discretion), used and cultivated by the Company’s properly licensed subsidiaries, affiliates or commercial partners.

Hugo Alves, President and Director of Auxly Cannabis Group commented: “Curative is a highly valued partner to Auxly, having been a part of the Auxly family since the inception of the Company. That being said, we could not be more pleased to have reached this stage of the project and to be signing a definitive agreement with Curative. Curative’s optimization of indoor cultivation combined with their unique genetics will provide a highly desirable product offering to the Canadian recreational cannabis markets and to the Auxly platform as a whole. We are pleased to be working with Dave, Scott and their team as they build out additional phases of this project and bring their product to market.


Auxly Congratulates Streaming Partner Lotus Ventures on Obtaining Cannabis Licences From Health Canada

VANCOUVER, British Columbia, March 11, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that its streaming partner, Lotus Ventures Inc. (“Lotus”), has been granted a “standard cultivation” licence and a “sale for medical purposes” licence by Health Canada pursuant to the Cannabis Act and Cannabis Regulations. The licences give Lotus the ability to begin cultivation at its fully constructed 22,500 square-foot facility in Armstrong, British Columbia (the “Facility”).
Hugo Alves, President of Auxly said: “We want to congratulate Dale, Stephen, Scott, Carl, Monica and the rest of the Lotus team on obtaining their Cannabis Act licences! This is an important step for Auxly as we continue to diversify our supply chain, utilizing a network of subsidiaries and partners to provide reliable sources of diverse raw product. Lotus is a partner that we value deeply, being one of Auxly’s first streaming partners. We look forward to continuing to work closely with the team at Lotus during these exciting new phases of their business.”
Deal Terms with Lotus
Pursuant to the definitive agreement entered into on September 11, 2018 (the “Transaction”), Auxly advanced $4,000,000 to Lotus to partially fund the completion of the Facility, which was in addition to Auxly’s $1,000,000 subscription of units of Lotus completed in January 2018. After completion of the Transaction, Auxly owned 5,755,868 common shares of Lotus and 1,000,000 five-year share purchase warrants exercisable at a price of $0.70. Additionally, Auxly is entitled to purchase or otherwise direct the sale of 50% of the Facility’s total production, which is expected to be 2,000 kg of cannabis per annum. Auxly also retains a right of first refusal to purchase the remaining 50% of cultivation output from the Facility, as well as a right of first refusal to finance a prescribed portion of the first expansion to the Facility and all or a portion of any further expansions of the Facility.
Other Business
The Company also announces that it has settled CDN$441,000 of debt in consideration for the issuance of 450,000 common shares of the Company at a price of $0.98 per common share. The common shares issued pursuant to the shares for debt settlement will be subject to a statutory four month and one day hold period.

Auxly Announces Completion of Inverell S.A. Acquisition

The Transaction positions the Company as a leader in the global CBD economy with a highly efficient, low-cost source of cannabinoids for international distribution, including through the Company's strategic partnership with ICC International Cannabis Corporation Inc. (CSE: WRLD) which provides the Company with access to 16 markets through a network of 35,000 pharmacies. Importantly, the low cost, high purity CBD produced by Inverell gives the Company a long-term and stable supply of CBD to support the research, development and manufacturing of cannabis-derived products at Dosecann Inc., the Company's wholly-owned Licensed Processor facility located in Prince Edward Island, Canada.

Hugo Alves, President and Director of Auxly Cannabis Group, commented: “We are incredibly pleased with progress that Inverell has made on the cultivation of its 2019 crop of CBD-rich hemp and on the broader development of the business as a stand-alone entity in the Auxly platform. In a very short period, Inverell has exceeded its 2018 planting target of 150 hectares of hemp plants and has made significant strides forward on the development of its world-class extraction facility located in the Parque de las Ciencias. We continue to believe that the low cost and high volume access to CBD molecules, through our ownership in Inverell, positions Auxly to be a leader in the global value-added cannabinoid-based product markets.”

("Acquisition Agreement”) to acquire all of the outstanding securities of Dosecann Inc. (“Dosecann”).

Dosecann is a late-stage “Licensed Dealer” applicant pursuant to the Narcotic Control Regulations with a purpose-built 42,000 square foot facility located in Charlottetown, Prince Edward Island.   

Pursuant to the Acquisition Agreement, Cannabis Wheaton will acquire all of the outstanding securities of Dosecann (the “Dosecann Securities”) by way of a “three-cornered amalgamation” (the “Acquisition”). Upon the completion of the Acquisition, Dosecann will become a wholly-owned subsidiary of Cannabis Wheaton.

As consideration for the Dosecann Securities, the Company will pay the holders of the Dosecann Securities an aggregate of up to $38,000,000, payable in common shares of Cannabis Wheaton (the “Consideration Shares”), subject to the satisfaction of certain post-closing time and performance-based milestones. As part of the Acquisition, all outstanding convertible securities of Dosecann will either be converted into Dosecann common shares and exchanged for Consideration Shares on the closing of the Acquisition (the “Closing”), or will otherwise be exchanged for convertible securities of Cannabis Wheaton based on the exchange ratio used in the Acquisition. 

The Dosecann principals, who collectively hold approximately 66.96% of the outstanding common shares of Dosecann, have agreed to enter into lock-up agreements in favour of Cannabis Wheaton restricting their ability to transfer their Consideration Shares (the “Locked-up Securities”) until the date that is 18 months following the Closing, provided that: (i) one-half of the Locked-Up Securities shall cease to be subject to the lock-up on the date that is 6 months following the Closing; and (ii) the remaining Locked-Up Securities shall cease to be subject to the lock-up in equal tranches on the 12th and 18th month anniversaries of the Closing.

The Acquisition is subject to a number of conditions, including the receipt of all required shareholder and regulatory approvals and the satisfaction or waiver of all conditions of closing under the Acquisition Agreement. The Transaction is expected to close on or about April 30, 2018.  
About Cannabis Wheaton (TSX-V:CBW)

Cannabis Wheaton is a collective of entrepreneurs with a passion for the cannabis industry past, present and future. Our mandate is to facilitate growth for our partners by providing them with financial support and sharing our collective industry experience. Our partners all have different visions, voices and brandvalues, and all share a common goal—to build a world-class industry based on ethics, diversity, quality and innovation.

About Dosecann

Dosecann Inc. is a PEI-based Licensed Dealer applicant currently completing the buildout of a 42,000 square foot GMP compliant facility. Within the purpose-built facility, Dosecann intends to accommodate product development, extraction, formulation, filling and packaging. Dosecann is developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets.


Auxly Announces Receipt of Cultivation and Processing Licences for Robinsons Cannabis Facility

VANCOUVER, British Columbia, April 08, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that its wholly-owned subsidiary, Robinsons Cannabis Inc. (“Robinsons”), has been granted standard cultivation and processing licences by Health Canada pursuant to the Cannabis Act and Cannabis Regulations. The licences give Robinsons the ability to begin cultivation at its fully constructed 27,700 square-foot facility in Kentville, Nova Scotia, which was purpose-built to produce high-quality cannabis.

Led by experienced head grower Andrew Robinson, Robinsons is uniquely positioned to capture the attention of luxury cannabis consumers, with operations built on a devotion to uncompromising quality and a premium cannabis experience. Robinsons products have consistently ranked the highest in terms of cannabinoid content, terpene content and overall quality when independently tested against 5,000 products supplied by various growers licenced in accordance with Canadian cannabis regulations. 

“We are thrilled to have achieved this major milestone,” says Andrew Robinson. “Our goal is to produce the best cannabis we can, for cannabis connoisseurs like ourselves. The licences will allow us to start production and take steps toward delivering a consistent final product focused on taste, smell, and potency.”

Hugo Alves, President of Auxly said: “This is a big milestone for one of our key subsidiaries and member of the Auxly family. We know that Andrew and his team are going to produce some of the best cannabis flower available in Canada and we can’t wait to share it with Canadian consumers. Robinsons is all about an unwavering commitment to quality. We hope to show cannabis connoisseurs, who to date have been generally disappointed with the flower offerings in the market, that passionate artisans operating in the regulated industry can produce an incredible product that reflects their pride and craftsmanship.”

Auxly expects that Robinsons’ premier products will be available for sale in the fourth quarter of this year, subject to receipt of sales authorization from Health Canada. With a focus on quality, Robinsons plans to release a limited amount of product to the market of approximately 1,100kg per year. 

Investor Relations:
For more information about investing in Cannabis Wheaton, please visit: http://www.wheatonincome.com or contact our Investor Relations Team: 
Email: IR@wheatonincome.com

Stay Connected: 
Follow up on Twitter @WheatonIncome

Media Enquiries (only): 
For media enquiries or to set up an interview please contact:
Sarah Bain, VP External Affairs 
Email: sarah@cannabiswheaton.com 
Phone: 613.230.5869




Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CBWTF News: Microgrid Tech That Could Change Cannabis 05/07/2019 08:37:13 AM
CBWTF News: Cannabis Stocks to Know this Week- THC Therapeutics, Inc. (THCT) 04/29/2019 01:20:00 PM
CBWTF News: CBD Retail Sales Growth Set to Explode 04/24/2019 02:40:53 PM
#2549  Sticky Note Auxly Announces Receipt of Cultivation and Processing Licences Diogenes of Sinope 04/08/19 07:19:02 AM
#2134  Sticky Note NEWS: Auxly Announces Completion of Inverell S.A. Acquisition europa7 01/09/19 11:43:40 AM
#2744   To the Moon yeayyy :) Brooklyn75 06/18/19 01:07:23 PM
#2741   Seems like the Dragon is the only one greendragon420 06/18/19 10:45:50 AM
#2738   Just another stock to short to oblivion. greendragon420 06/14/19 10:01:47 AM
#2737   Rock solid analysis Rook Crisco 06/12/19 06:57:34 PM
#2736   Good bye 58’s? Already? greendragon420 06/12/19 01:13:56 PM
#2735   Good bye 59’s greendragon420 06/11/19 04:36:35 PM
#2734   Junior went for a walk through at FSD PocketKK 06/10/19 08:59:01 PM
#2733   60’s were nice while they lasted, all of greendragon420 06/10/19 11:53:29 AM
#2732   Its also funny with that Facebook page anyone Brooklyn75 06/10/19 11:35:10 AM
#2731   Draggy So good to see you are RHF469usa 06/10/19 10:40:32 AM
#2728   First movers advantage does not apply here. “We greendragon420 06/07/19 09:11:39 AM
#2727   Agree, strong management team and the the planning Crisco 06/06/19 10:18:23 AM
#2726   Predictions continue to be incorrect regarding Auxly. Look TheGreatGreenRush 06/06/19 12:40:36 AM
#2725   “We’ve made a very conscious effort to delay Crisco 06/05/19 04:27:47 PM
#2724   Nope, wrong -Auxly Crisco 06/05/19 10:49:50 AM
#2723   Wonder if they will be putting the hammer greendragon420 06/04/19 04:05:52 PM
#2722   Good article on what dosecann does for auxly Crisco 06/04/19 11:47:01 AM
#2720   Let’s not talk about Dixie when it comes greendragon420 06/04/19 10:39:58 AM
#2719   lol more like DoseCANT greendragon420 06/04/19 10:36:32 AM
#2718   Dosecann will be instrumental here imo Crisco 06/04/19 09:01:46 AM
#2717   Here come the 40’sss greendragon420 06/03/19 12:50:33 PM
#2716   Well neither is their share price...It truly is Sunblazers 06/01/19 02:42:11 PM
#2713   Expenses Selling, general and administrative expenses 10,968,000 Plus your PocketKK 05/31/19 11:20:26 AM
#2712   You should get a new analyst 13 mil Crisco 05/31/19 09:17:54 AM
#2711   This is what my analyst’s told me. PocketKK 05/31/19 05:43:41 AM
#2710   I only need about 10% of that. greendragon420 05/30/19 04:46:40 PM
#2709   You read the fins, what’s the money being Crisco 05/30/19 04:26:40 PM
#2708   I hope much of that isn't being spent Brooklyn75 05/30/19 03:37:14 PM
#2707   My bad on the 31,000. I admit that greendragon420 05/30/19 07:53:15 AM
#2706   So if we did a reverse split, 10:1 greendragon420 05/30/19 07:50:50 AM
#2705   Math is tricky.... Crisco 05/29/19 08:57:21 PM
#2704   That’s a lot of pot. I understand kilo. greendragon420 05/29/19 08:17:20 PM
#2703   And Auxly has over $200m in cash. They TheGreatGreenRush 05/29/19 07:26:43 PM
#2702   Missed a zero bro. Try 310,000 kilograms. Kilo TheGreatGreenRush 05/29/19 07:25:35 PM
#2701   Great DD 310,000,000 grams, 31,000 kilograms. That’s great greendragon420 05/29/19 06:57:55 PM
#2700   Great DD on Leamington JV. This should be Crisco 05/29/19 01:21:56 PM
#2699   Auxly to Ultimately Receive 310,000,000 Grams/Per/Annum from Peter WeedWarrior 05/29/19 12:06:53 AM
#2698   Think that would have happened already Dg23 05/28/19 09:51:31 PM
#2697   455 mil in assets with a market cap Crisco 05/28/19 07:25:06 AM
#2696   Full Sedar report here, search Auxly Crisco 05/28/19 07:21:29 AM
#2695   Also didn’t see one thing about their JV greendragon420 05/28/19 06:20:34 AM
#2694   Wow, another quarter of generating less than 1 greendragon420 05/28/19 06:10:19 AM
#2693   Auxly Cannabis Reports Q1 2019 Financial Results and wsstocks 05/27/19 04:55:22 PM
#2692   Ok, You read the financials? Where is the Crisco 05/27/19 10:47:17 AM
#2691   Same old nothing. 2 years later working on Brooklyn75 05/27/19 10:28:54 AM
#2690   In the report it’s clear the focus is Crisco 05/27/19 10:17:26 AM
#2689   Waiting on export lic to be granted for Crisco 05/27/19 10:15:34 AM
#2688   This company is great at not impressing anyone! Sunblazers 05/27/19 08:15:50 AM
#2687   Why is there no information on Inverell’s first PocketKK 05/27/19 08:02:32 AM
#2686   http://www.globenewswire.com/news-release/2019/05/27/1850413/0/en/Auxly-Reports- Crisco 05/27/19 07:33:53 AM